diabetes

Big News for These 2 Diabetes Hopefuls

Big News for These 2 Diabetes Hopefuls

Motley Fool

3 Big Stories Health-Care Investors Should Be Watching This Week

3 Big Stories Health-Care Investors Should Be Watching This Week

Motley Fool

Assessing Arena's Belviq As A Diabesity Drug

Assessing Arena's Belviq As A Diabesity Drug

Seeking Alpha

Janssen submits NDA to FDA for canagliflozin/metformin

Janssen submits NDA to FDA for canagliflozin/metformin

Yahoo/Fly on the Wall

The Next Wave of Diabetes Dominance

The Next Wave of Diabetes Dominance

Motley Fool

Sanofi's last on the list to buy Bayer's glucose devices

Sanofi's last on the list to buy Bayer's glucose devices

Mass Device

Bayer diabetes unit sale unlikely - sources

Bayer diabetes unit sale unlikely - sources

Reuters

Submitted by moderatorj on Wed, 12/05/2012 - 00:05

Diabetes: Medtronic wins CE Mark for Sentrino continuous glucose monitor

Diabetes: Medtronic wins CE Mark for Sentrino continuous glucose monitor

Mass Device

Glaxo Doubts GLP-1s Would Be Cleared as Drugs for Obesity

Glaxo Doubts GLP-1s Would Be Cleared as Drugs for Obesity

Bloomberg

Long MannKind's Afrezza: Shares Versus A Bull Call Spread

Long MannKind's Afrezza: Shares Versus A Bull Call Spread

Seeking Alpha